Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02232516
Title Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Northwestern University
Indications

angioimmunoblastic T-cell lymphoma

anaplastic large cell lymphoma

mature T-cell and NK-cell lymphoma

mycosis fungoides

peripheral T-cell lymphoma

Therapies

Lenalidomide + Romidepsin

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST